Threshold-based insulin-pump interruption for reduction of hypoglycemia
New England Journal of Medicine,  Evidence Based Medicine  Clinical Article

Bergenstal RM et al. – The threshold–suspend feature of sensor–augmented insulin pumps is designed to minimize the risk of hypoglycemia by interrupting insulin delivery at a preset sensor glucose value. Authors evaluated sensor–augmented insulin–pump therapy with and without the threshold–suspend feature in patients with nocturnal hypoglycemia. This study showed that over a 3–month period the use of sensor–augmented insulin–pump therapy with the threshold–suspend feature reduced nocturnal hypoglycemia, without increasing glycated hemoglobin values.

Methods

  • randomly assigned patients with type 1 diabetes and documented nocturnal hypoglycemia to receive sensor–augmented insulin–pump therapy with or without the threshold–suspend feature for 3 months.
  • The primary safety outcome was the change in the glycated hemoglobin level.
  • The primary efficacy outcome was the area under the curve (AUC) for nocturnal hypoglycemic events.
  • Two–hour threshold–suspend events were analyzed with respect to subsequent sensor glucose values.

Results

  • A total of 247 patients were randomly assigned to receive sensor–augmented insulin–pump therapy with the threshold–suspend feature (threshold–suspend group, 121 patients) or standard sensor–augmented insulin–pump therapy (control group, 126 patients).
  • The changes in glycated hemoglobin values were similar in the two groups.
  • The mean AUC for nocturnal hypoglycemic events was 37.5% lower in the threshold–suspend group than in the control group (980+–1200 mg per deciliter [54.4+–66.6 mmol per liter]×minutes vs. 1568+–1995 mg per deciliter [87.0+–110.7 mmol per liter]×minutes, P<0.001).
  • Nocturnal hypoglycemic events occurred 31.8% less frequently in the threshold–suspend group than in the control group (1.5+–1.0 vs. 2.2+–1.3 per patient–week, P<0.001).
  • The percentages of nocturnal sensor glucose values of less than 50 mg per deciliter (2.8 mmol per liter), 50 to less than 60 mg per deciliter (3.3 mmol per liter), and 60 to less than 70 mg per deciliter (3.9 mmol per liter) were significantly reduced in the threshold–suspend group (P<0.001 for each range).
  • After 1438 instances at night in which the pump was stopped for 2 hours, the mean sensor glucose value was 92.6+–40.7 mg per deciliter (5.1+–2.3 mmol per liter).
  • Four patients (all in the control group) had a severe hypoglycemic event; no patients had diabetic ketoacidosis.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Internal Medicine Articles

1 Corticosteroid treatment for community-acquired pneumonia - the STEP trial: study protocol for a randomized controlled trial Full Text Trials, July 16, 2014    Free full text    Evidence Based Medicine    Clinical Article

2 Screening pelvic examinations in asymptomatic, average-risk adult women: An evidence report for a clinical practice guideline from the American college of physicians Annals of Internal Medicine, July 2, 2014    Evidence Based Medicine    Clinical Article

3 Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: A randomized clinical trial JAMA, July 10, 2014    Evidence Based Medicine    Clinical Article

4 Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial JAMA Internal Medicine, July 15, 2014    Evidence Based Medicine    Clinical Article

5 Statins and physical activity in older men the osteoporotic fractures in men study JAMA Internal Medicine, June 12, 2014    Evidence Based Medicine    Clinical Article

6 Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials BMJ, June 11, 2014    Evidence Based Medicine    Clinical Article

7 Challenges of infectious diseases in the USA The Lancet, July 3, 2014    Review Article    Clinical Article

8 Vitamin D and Calcium Supplementation to Prevent Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement Full Text Annals of Internal Medicine, February 26, 2013    Free full text    Clinical Guideline

9 Avoidance of sun exposure is a risk factor for all-cause mortality: results from the MISS cohort Journal of Internal Medicine, April 22, 2014    Evidence Based Medicine    Clinical Article

10 Association between melanocytic nevi and risk of breast diseases: The French E3N Prospective Cohort Full Text PLoS Medicine, July 1, 2014    Free full text    Evidence Based Medicine    Clinical Article

11 Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: A meta-analysis JAMA, June 26, 2014    Evidence Based Medicine    Clinical Article

12 Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial The Lancet, July 25, 2014    Evidence Based Medicine    Clinical Article

13 Changes in circulating leptin levels during acute stress and associations with craving in abstinent smokers: A preliminary investigation Psychoneuroendocrinology, June 20, 2014    Clinical Article

14 CPAP, weight loss, or both for obstructive sleep apnea New England Journal of Medicine, June 13, 2014    Evidence Based Medicine    Clinical Article

15 Treatment of venous thromboembolism Full Text JAMA, February 19, 2014    Free full text    Evidence Based Medicine    Clinical Article

16 Tea consumption and leukemia risk: A meta-analysis Tumor Biology, February 12, 2014    Evidence Based Medicine    Clinical Article

17 Glycated hemoglobin measurement and prediction of cardiovascular disease JAMA, March 26, 2014    Evidence Based Medicine

18 Many sudden cardiac arrests preceded by warning signs Circulation, November 20, 2013    Evidence Based Medicine    Clinical Article

19 Risk of pediatric celiac disease according to HLA haplotype and country New England Journal of Medicine, July 7, 2014    Evidence Based Medicine    Clinical Article

20 Resveratrol levels and all-cause mortality in older community-dwelling adults JAMA Internal Medicine, May 13, 2014    Evidence Based Medicine    Clinical Article

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close